POLMON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Polmon, and what generic alternatives are available?
Polmon is a drug marketed by Capellon Pharms Llc and is included in one NDA.
The generic ingredient in POLMON is dexchlorpheniramine maleate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLMON?
- What are the global sales for POLMON?
- What is Average Wholesale Price for POLMON?
Summary for POLMON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | POLMON at DailyMed |
US Patents and Regulatory Information for POLMON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capellon Pharms Llc | POLMON | dexchlorpheniramine maleate | SYRUP;ORAL | 202520-001 | Jul 16, 2018 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
